Literature DB >> 7865496

Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.

P D Hrdina1, D Bakish, J Chudzik, A Ravindran, Y D Lapierre.   

Abstract

The uptake of [3H]5-HT and the density (Bmax) as well as affinity (Kd) of 5-HT uptake sites labelled with [3H]paroxetine and of 5-HT2 receptors labelled by [3H]LSD were determined in platelets from 25 medication-free patients with major depression and 20 normal controls. The density (Bmax) of 5-HT2 receptors was found to be significantly increased (by 52%) in platelets from depressed patients, particularly females. No changes were found in the affinity (Kd) of 5-HT2 receptors and in 5-HT uptake or [3H]paroxetine binding parameters. Density of 5-HT2 receptors positively correlated with that of [3H]paroxetine sites in control but not in depressed subjects. No correlation was found between the HAMD scores and Bmax of [3H]LSD binding. The results suggest that upregulation of platelet 5-HT2 receptors is a useful biological marker in major depression, particularly in females.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7865496      PMCID: PMC1188653     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  45 in total

1.  3H-imipramine binding sites in platelets from psychiatric patients.

Authors:  E T Mellerup; P Plenge; R Rosenberg
Journal:  Psychiatry Res       Date:  1982-10       Impact factor: 3.222

2.  Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.

Authors:  R C Arora; V Wunnicke; H Y Meltzer
Journal:  Biol Psychiatry       Date:  1985-01       Impact factor: 13.382

3.  Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

Authors:  G R Heninger; D S Charney; D E Sternberg
Journal:  Arch Gen Psychiatry       Date:  1984-04

4.  High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.

Authors:  E T Mellerup; P Plenge; M Engelstoft
Journal:  Eur J Pharmacol       Date:  1983-12-23       Impact factor: 4.432

5.  Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.

Authors:  D P Geaney; M Schächter; J M Elliot; D G Grahame-Smith
Journal:  Eur J Pharmacol       Date:  1984-01-13       Impact factor: 4.432

6.  Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.

Authors:  H Y Meltzer; B Umberkoman-Wiita; A Robertson; B J Tricou; M Lowy; R Perline
Journal:  Arch Gen Psychiatry       Date:  1984-04

7.  Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites.

Authors:  D de Chaffoy de Courcelles; J E Leysen; F De Clerck; H Van Belle; P A Janssen
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

8.  Serotonin uptake in blood platelets of psychiatric patients.

Authors:  H Y Meltzer; R C Arora; R Baber; B J Tricou
Journal:  Arch Gen Psychiatry       Date:  1981-12

9.  Decreased imipramine binding in the brains of patients with depressive illness.

Authors:  E K Perry; E F Marshall; G Blessed; B E Tomlinson; R H Perry
Journal:  Br J Psychiatry       Date:  1983-02       Impact factor: 9.319

10.  Tryptophan depletion causes a rapid lowering of mood in normal males.

Authors:  S N Young; S E Smith; R O Pihl; F R Ervin
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  20 in total

Review 1.  Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.

Authors:  Gilberto Paz-Filho; Julio Licinio; Ma-Li Wong
Journal:  Braz J Psychiatry       Date:  2010-06       Impact factor: 2.697

Review 2.  Platelets and depression in cardiovascular disease: A brief review of the current literature.

Authors:  Marlene S Williams
Journal:  World J Psychiatry       Date:  2012-12-22

3.  A new biological test for suicidality?

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

4.  Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls.

Authors:  K M Lawrence; F De Paermentier; S Lowther; M R Crompton; C L Katona; R W Horton
Journal:  J Psychiatry Neurosci       Date:  1997-05       Impact factor: 6.186

5.  Serotonin transport kinetics correlated between human platelets and brain synaptosomes.

Authors:  Jeffrey L Rausch; Maria E Johnson; Junqing Li; Julian Hutcheson; Benjamin M Carr; Katina M Corley; Amanda B Gowans; Joseph Smith
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

6.  Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression.

Authors:  Marlene S Williams; Roy C Ziegelstein; Una D McCann; Neda F Gould; Tamara Ashvetiya; Dhananjay Vaidya
Journal:  Psychosom Med       Date:  2019-05       Impact factor: 4.312

7.  Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects.

Authors:  J Roggenbach; B Müller-Oerlinghausen; L Franke; R Uebelhack; S Blank; B Ahrens
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

Review 8.  Biological basis of suicide and suicidal behavior.

Authors:  Ghanshyam N Pandey
Journal:  Bipolar Disord       Date:  2013-06-15       Impact factor: 6.744

Review 9.  Psychobiology of depression/distress in congestive heart failure.

Authors:  Kaki M York; Mustafa Hassan; David S Sheps
Journal:  Heart Fail Rev       Date:  2008-03-27       Impact factor: 4.214

10.  Human genetic variation and mental disorders.

Authors:  Bárbara Arias; A Rosa; Lourdes Fañanás
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.